Kratom Science | 2021

Two United States Patents relating to Kratom Extract and specific alkaloids.

January 1, 2018

Kratom (Milragynia speciosa korth) is recognized increasingly as a remedy for opioid Withdrawal by individuals Who self-treat chronic pain and/or generalized substance abuse. For example, opioid Withdrawal from an abrupt cessation of opiate abuse may be self-managed by using Kratom. Further, high-throughput molecular screening identi?ed that a major component of Kratom (i.e., for example, mitragyinine) displayed high binding a?inity at mu, delta and kappa opiate receptors. The present invention contemplates that Kratom extract may also be useful for the treatment of other addictive drugs besides opiate derivatives.

Have a look

Here you can see the patent given to Takayama for 7-Hydroxymitragynine an indole alkaloid derivatives having opioid receptor agonistic effect, and therapeutic compositions and methods relating to the same.

Have a look

Kratom Science | 2021 | kratom.com | info@kratom.com

Image subhead (if there is an image)

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Get updates from Kratom.com

New product alerts, discounts and merch opps

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.